[
    [
        {
            "time": "",
            "original_text": "贝达药业：恩沙替尼计划于明年向美国FDA申报一线治疗适应症的上市申",
            "features": {
                "keywords": [
                    "贝达药业",
                    "恩沙替尼",
                    "FDA",
                    "一线治疗",
                    "上市申报"
                ],
                "sentiment_score": 0.7,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "医药"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "false",
                "ts_effect_direction": ""
            },
            "scores": {
                "News_content": "贝达药业：恩沙替尼计划于明年向美国FDA申报一线治疗适应症的上市申",
                "Correlation": 9,
                "Sentiment": 8,
                "Importance": 9,
                "Impact": 8,
                "Duration": 7,
                "Entity_Density": 8,
                "Market_Scope": 5,
                "Time_Proximity": 6,
                "Headline_Structure": 7,
                "Source_Recency": 8
            }
        },
        {
            "time": "",
            "original_text": "人民金融·创新药指数涨1.39% 11个创新药获批临床",
            "features": {
                "keywords": [
                    "创新药指数",
                    "涨1.39%",
                    "创新药",
                    "获批临床"
                ],
                "sentiment_score": 0.85,
                "policy_related": "false",
                "investment_strategy": "false",
                "sector_focus": [
                    "医药"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "News_content": "人民金融·创新药指数涨1.39% 11个创新药获批临床",
                "Correlation": 6,
                "Sentiment": 7,
                "Importance": 7,
                "Impact": 6,
                "Duration": 5,
                "Entity_Density": 4,
                "Market_Scope": 8,
                "Time_Proximity": 7,
                "Headline_Structure": 6,
                "Source_Recency": 7
            }
        }
    ]
]